Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.89 USD | -0.52% |
|
-0.52% | +86.52% |
06-24 | Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained | MT |
Evolution of the average Target Price on Harrow, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Harrow, Inc.
Craig-Hallum | |
Lake Street | |
B. Riley | |
Aegis Capital |
EPS Revisions
- Stock Market
- Equities
- HROW Stock
- Consensus Harrow, Inc.